Image

Impact of Insomnia Treatment on Brain Responses During Resting-state and Cognitive Tasks

Impact of Insomnia Treatment on Brain Responses During Resting-state and Cognitive Tasks

Recruiting
25-65 years
All
Phase N/A

Powered by AI

Overview

Individuals with chronic insomnia have persistent difficulty falling and staying asleep, as well as complaints of altered daytime functioning that may be associated with cognitive impairments. The neural processes underlying these daytime complaints may involve abnormal activation of brain regions and neural networks involved in working memory, memory encoding and emotions. The goal of this study is to assess whether a psychological treatment for insomnia will reverse these abnormalities in brain responses to cognitive tasks and at rest. A secondary objective of the study is to characterize impairments in attentional processing and assess if the impairments can be reversed by the psychological treatment. We hypothesized that the psychological treatment for insomnia will lead to a normalization of the brain responses to working memory, declarative memory encoding, insomnia-related stimuli, and the functional connectivity within the default-mode and limbic networks.

Description

Study hypothesis

Brain responses associated with working memory task and declarative memory encoding will be decreased in chronic insomnia compared to good sleepers and, among individuals with chronic insomnia, cognitive-behavioral therapy for insomnia will lead to larger recovery in these brain responses, compared to a 3-month wait period.

Brain responses to emotional stimulation, especially to insomnia-related stimuli, will be increased in chronic insomnia compared to good sleepers, and, among individuals with chronic insomnia, cognitive-behavioral therapy for insomnia will lead to larger reduction in these brain responses, compared to a 3-month wait period.

Connectivity in the default-mode and limbic networks during resting-state will be increased in chronic insomnia compared to good sleepers, and, among individuals with chronic insomnia, cognitive-behavioral therapy for insomnia will lead to larger reduction in this connectivity, compared to a 3-month wait period.

Eligibility

Inclusion Criteria:

80 participants with chronic primary insomnia (40 per group) 40 good sleepers

Exclusion Criteria:

  1. Older than 65 y.o. or younger than 25 y.o.
  2. Contraindication to the MRI scanning
  3. Current neurological disorder
  4. Past history of brain lesion
  5. Major surgery (i.e., requiring general anesthesia) in the past 3 months
  6. Untreated thyroid disorder
  7. Chronic pain syndrome self-reported as interfering with sleep
  8. Recent and severe infection in the past 3 months
  9. Active cancer, or remitted cancer with cancer treatment within the last 2 years
  10. Stroke
  11. Myocardial infarct
  12. Arterial bypass or angioplasty
  13. Pacemaker
  14. Heart failure causing limitation of ordinary physical activity
  15. Renal insufficiency
  16. Sleep apnea with an apnea-hypopnea index > 5/h
  17. Restless legs syndrome with symptoms 3 days or more per week
  18. Periodic limb movements during sleep with index > 15/h
  19. REM-sleep behavior disorder
  20. Narcolepsy and other central disorders of hypersomnolence
  21. Sleepwalking more than once/month
  22. Having worked on night shifts or rotating shifts for more than 2 weeks in the last 3 months or expecting to do so during the study period
  23. Severe mental disorders: bipolar disorder (Type I), schizophrenia, anxiety disorders, major depressive disorder, current substance use disorder, current post-traumatic stress disorder
  24. Current suicidality
  25. Frequent alcohol consumption (>10 glasses/week) or use of cannabis (more than once a week) or illicit drugs (more than once a month)
  26. Smoking cigarettes more than 10 cigarettes/day
  27. Pregnant or breastfeeding women
  28. Current psychotherapy or past cognitive-behavioural therapy for insomnia
  29. Current use of medication for depression or anxiety
  30. Unable to stop hypnosedative medications for at least 2 weeks prior to the first assessment
  31. For good sleepers: insomnia symptoms more than 3 times/ week.

Study details
    Chronic Insomnia

NCT04024787

Concordia University, Montreal

16 February 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.